These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9453311)

  • 1. Lysophosphatidylcholine stimulates MAP kinase activity in rat vascular smooth muscle cells.
    Yamakawa T; Eguchi S; Yamakawa Y; Motley ED; Numaguchi K; Utsunomiya H; Inagami T
    Hypertension; 1998 Jan; 31(1 Pt 2):248-53. PubMed ID: 9453311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidylcholine stimulates activator protein 1 and the c-Jun N-terminal kinase activity.
    Fang X; Gibson S; Flowers M; Furui T; Bast RC; Mills GB
    J Biol Chem; 1997 May; 272(21):13683-9. PubMed ID: 9153219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of MAP kinase blocks insulin-mediated DNA synthesis and transcriptional activation of c-fos by Elk-1 in vascular smooth muscle cells.
    Xi XP; Graf K; Goetze S; Hsueh WA; Law RE
    FEBS Lett; 1997 Nov; 417(3):283-6. PubMed ID: 9409734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidylcholine activates extracellular signal-regulated kinases 1/2 through reactive oxygen species in rat vascular smooth muscle cells.
    Yamakawa T; Tanaka S; Yamakawa Y; Kamei J; Numaguchi K; Motley ED; Inagami T; Eguchi S
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):752-8. PubMed ID: 12006386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidylcholine induces early growth response factor-1 expression and activates the core promoter of PDGF-A chain in vascular endothelial cells.
    Morimoto M; Kume N; Miyamoto S; Ueno Y; Kataoka H; Minami M; Hayashida K; Hashimoto N; Kita T
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):771-6. PubMed ID: 11348873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JunB forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells.
    Rao GN; Katki KA; Madamanchi NR; Wu Y; Birrer MJ
    J Biol Chem; 1999 Feb; 274(9):6003-10. PubMed ID: 10026227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein tyrosine kinase activity is required for oxidant-induced extracellular signal-regulated protein kinase activation and c-fos and c-jun expression.
    Rao GN
    Cell Signal; 1997 Feb; 9(2):181-7. PubMed ID: 9113418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidylcholine phosphorylates CREB and activates the jun2TRE site of c-jun promoter in vascular endothelial cells.
    Ueno Y; Kume N; Miyamoto S; Morimoto M; Kataoka H; Ochi H; Nishi E; Moriwaki H; Minami M; Hashimoto N; Kita T
    FEBS Lett; 1999 Aug; 457(2):241-5. PubMed ID: 10471787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts).
    Hattori Y; Suzuki M; Hattori S; Kasai K
    Hypertension; 2002 Jan; 39(1):22-8. PubMed ID: 11799073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers.
    McBride K; Nemer M
    Mol Cell Biol; 1998 Sep; 18(9):5073-81. PubMed ID: 9710591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The growth-promoting effect of low-density lipoprotein may Be mediated by a pertussis toxin-sensitive mitogen-activated protein kinase pathway.
    Sachinidis A; Seewald S; Epping P; Seul C; Ko Y; Vetter H
    Mol Pharmacol; 1997 Sep; 52(3):389-97. PubMed ID: 9281600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP inhibition of thrombin-induced growth in vascular smooth muscle cells correlates with decreased JNK1 activity and c-Jun expression.
    Rao GN; Runge MS
    J Biol Chem; 1996 Aug; 271(34):20805-10. PubMed ID: 8702835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by eicosapentaenoic acid of oxidized-LDL- and lysophosphatidylcholine-induced human coronary artery smooth muscle cell production of endothelin.
    Kohno M; Ohmori K; Wada Y; Kondo I; Noma T; Fujita N; Mizushige K; Mandal AK
    J Vasc Res; 2001; 38(4):379-88. PubMed ID: 11455209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells.
    Hamaguchi A; Kim S; Izumi Y; Zhan Y; Yamanaka S; Iwao H
    Hypertension; 1999 Jul; 34(1):126-31. PubMed ID: 10406835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells: mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxicity.
    Jing Q; Xin SM; Cheng ZJ; Zhang WB; Zhang R; Qin YW; Pei G
    Circ Res; 1999 Apr; 84(7):831-9. PubMed ID: 10205151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidylcholine activates transcription factor NF-kappaB and AP-1 in AR42J cells.
    Masamune A; Sakai Y; Yoshida M; Satoh A; Satoh K; Shimosegawa T
    Dig Dis Sci; 2001 Sep; 46(9):1871-81. PubMed ID: 11575438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
    Wen-Sheng W
    Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin suppression of proliferation of vascular smooth muscle cells: correlation with c-jun and JNK.
    Lu LH; Lee SS; Huang HC
    Br J Pharmacol; 1998 Jul; 124(6):1227-37. PubMed ID: 9720795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling pathways in the induction of c-fos and c-jun proto-oncogenes by 3-methylcholanthrene.
    Ainbinder E; Bergelson S; Daniel V
    Recept Signal Transduct; 1997; 7(4):279-89. PubMed ID: 9633828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.